Comparison of the resistance ratio and proportion methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis

Journal of the Medical Association of Thailand

Volumn 84, Issue 10, 2001, Pages 1467-1476

  Tansuphasiri, Unchalee ^a   Subpaiboon, Sirimart ^b   Rienthong, Somsak ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Bang Khla Hospital   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Antimicrobial Susceptibility Testing; Mycobacterium tuberculosis; Proportion Method; Resistance Ratio

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; INTERMETHOD COMPARISON; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 0035705755     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. American Thoracic Society and Centers for Disease Control. Nosocomial transmission of multidrug resistant tuberculosis among HIV-infected persons-Florida and New York 1988-1991. Morbid Mortal Wkly Rep 1991; 40: 585-91.
2. Edlin BR, Tokars JI, Grieco MH. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Eng J Med 1992; 326: 1514-21.
3. Fischi MA, Uttamchandani RB, Daikos GL, et al. An outbreak of tuberculosis caused by multipledrug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992; 117: 177-83.
4. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States 1985 through 1992. JAMA 1994; 272: 535-9.
5. Snider DE Jr, Raviglione MC, Kochi A. Global, burden of tuberculosis. In : Bloom BR, ed. Tuberculosis. Washington, DC. : American Society for Microbiology, 1995: 3-11.
6. Pio A, Luelmo F, Kumaresan J, Spinaci S. National tuberculosis programme review: Experience over the period 1990-1995. Bull WHO 1997; 75: 569-81.
7. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin Infect Dis 1997; 24 (Suppl 1): 121-30.
8. Payanandana V, Rienthong S, Rienthong D, Ratanavichit L, Kortwong P, Lamunsab J. Interim report of drug resistance surveillance, Thailand 1997-1998 (Abstract). Int J Tuberc Lung Dis 1998; 2 (Suppl 2): 181.
9. Payanandana V, Rienthong D, Rienthong S, Ratanavichit L, Kim SJ, Sawert H. Surveillance for antituberculosis drug resistance in Thailand : Results from a national survey. Thai J Tuberc Chest Dis 2000; 21: 1-8.
10. Bennedsen J, Larsen SO. Examination of tubercle bacilli by fluorescence microscopy. Scand J Resp Dis 1966; 47: 114-20.
11. Kent PT, Kubica GP. Public Health Mycobacteriology. A guide for the level III laboratory Centers for Disease Control: Atlanta; 1985.
12. Mitchison DA. Problems of drug resistance. Brit Med Bull 1954; 10: 115.
13. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull WHO 1969; 41: 21-45.
14. Tuberculosis Programme World Health Organization/International Union Against Tuberculosis and Lung Disease. Guidelines for surveillance of drug resistance tuberculosis. Document WHO/TB/94. 178, Geneva: World Health Organization, 1994.
15. Runyon EH, Karlson AG, Kubica GP, et al. Mycobacterium. In : Lennette EH, Balows A, Hausler WJ Jr, Truant JP, eds. Manual of clinical microbiology. 3rd. Washington, DC. : American Society of Microbiology, 1980: 150-79.
16. Siddiqi SH, Hawkins JE, Laszlo A. Intetlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol 1985; 22: 919-23.
17. Rist N. Nature and development of resistance of tubercle bacilli to chemotherapeutic agents. In: Barry CV, ed. Chemotherapy of tuberculosis. London : Butterworts, 1964: 192-227.
18. Marks JA. System for examination of tubercle bacilli and other mycobacteria. Tuberc 1976; 57: 207-25.
19. Wanger A, Mills K. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampicin, and streptomycin by using E test. J Clin Microbiol 1996; 34: 1672-6.
20. Franzblau SG, Witzig RS, McLaughlin JC, et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate alamar blue assay. J Clin Microbiol 1998; 36: 362-6.
21. Casabona NM, Mimo DX, Gonzalez T, Rossello J, Arcalis L. Rapid method for testing susceptibility of Mycobacterium tuberculosis by using DNA probes. J Clin Microbiol 1997; 35: 2521-5.
22. Nachamkin I, Kang C, Weinstein MP. Detection of resistance to isoniazid, rifampicin and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis 1997; 24: 894-900.
23. Gutierrez MC, Vincent V, Aubert D, et al. Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area. J Clin Microbiol 1998; 36: 486-92.
24. Payanandana V, Kladphuang B, Somsong W, Jittimanee S. Battle against TB national tuberculosis programme Thailand. Tuberculosis Division, Department of Communicable Disease Control, Ministry of Public Health, Thailand, 1999.